356 related articles for article (PubMed ID: 25126056)
1. Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Irwin RW; Solinsky CM; Brinton RD
Front Cell Neurosci; 2014; 8():203. PubMed ID: 25126056
[TBL] [Abstract][Full Text] [Related]
2. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
Irwin RW; Brinton RD
Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
[TBL] [Abstract][Full Text] [Related]
3. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
Irwin RW; Wang JM; Chen S; Brinton RD
Front Endocrinol (Lausanne); 2011; 2():117. PubMed ID: 22654847
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
Wang T; Yao J; Chen S; Mao Z; Brinton RD
Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
[TBL] [Abstract][Full Text] [Related]
5. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
Irwin RW; Solinsky CM; Loya CM; Salituro FG; Rodgers KE; Bauer G; Rogawski MA; Brinton RD
PLoS One; 2015; 10(6):e0128313. PubMed ID: 26039057
[TBL] [Abstract][Full Text] [Related]
6. Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease.
Chen S; Wang T; Yao J; Brinton RD
Neurotherapeutics; 2020 Oct; 17(4):1813-1824. PubMed ID: 32632771
[TBL] [Abstract][Full Text] [Related]
7. Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.
Raikes AC; Hernandez GD; Matthews DC; Lukic AS; Law M; Shi Y; Schneider LS; Brinton RD
Alzheimers Dement (N Y); 2022; 8(1):e12258. PubMed ID: 35310526
[TBL] [Abstract][Full Text] [Related]
8. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
Noorbakhsh F; Baker GB; Power C
Front Cell Neurosci; 2014; 8():134. PubMed ID: 24917787
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone pleiotropic action in neurons and astrocytes: calcium signaling as a unifying mechanism.
Wang T; Chen S; Mao Z; Shang Y; Brinton RD
Front Endocrinol (Lausanne); 2023; 14():1286931. PubMed ID: 38189047
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
[TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone: Regenerative therapeutic to restore neurological health.
Hernandez GD; Brinton RD
Neurobiol Stress; 2022 Nov; 21():100502. PubMed ID: 36532370
[TBL] [Abstract][Full Text] [Related]
13. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
14. Brief but chronic increase in allopregnanolone cause accelerated AD pathology differently in two mouse models.
Bengtsson SK; Johansson M; Backstrom T; Nitsch RM; Wang M
Curr Alzheimer Res; 2013 Jan; 10(1):38-47. PubMed ID: 23157375
[TBL] [Abstract][Full Text] [Related]
15. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration.
Meyer M; Garay LI; Kruse MS; Lara A; Gargiulo-Monachelli G; Schumacher M; Guennoun R; Coirini H; De Nicola AF; Gonzalez Deniselle MC
J Steroid Biochem Mol Biol; 2017 Nov; 174():201-216. PubMed ID: 28951257
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
Hirsch-Reinshagen V; Wellington CL
Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
[TBL] [Abstract][Full Text] [Related]
18. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress.
Evans J; Sun Y; McGregor A; Connor B
Neuropharmacology; 2012 Dec; 63(8):1315-26. PubMed ID: 22939998
[TBL] [Abstract][Full Text] [Related]
19. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
20. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
